Globalisation

CRO market in Asia to see 'significant increase' through 2020

CRO market in Asia to see significant increase through 2020

The CRO market in Asia has “massive implications” as it continues to emerge as a preferred destination for clinical trials – a global market expected to reach $57bn by 2020.

Quartesian hiring 100 employees in 2017 as it expands globally

Quartesian hiring 100 employees in 2017 as it expands globally

(Image: iStock/oatawa)

Clinerion aims for 50m patients by Q2 2017 as it enters South America

(Image: iStock/scanrail)

Almac announces £27m global expansion

The CFDA report on clinical trial data follows a yearlong investigation initiated in 2015. (Image: iStock/Sky_Blue)

CFDA: reports of clinical trial data fraud 'not fact based'

Worldwide Clinical Trials opens new office in Warsaw, Poland. (Image: iStock/Tuomas_Lehtinen)

Worldwide Clinical Trials opens new facility in Poland

iCardiac Technologies, Inc., is a laboratory for cardiac safety and respiratory services. (Image: iStock/erthuz)

iCardiac collaborating with Japanese SMO to conduct cardiac safety studies

70% of new drugs registered in Europe in 2015 were tested in phase II-III clinical trials in Russia. (Image: iStock/eyegelb)

Marken expands capabilities with new pharma license at Moscow depot

(Image: iStock)

Ash Stevens acquired by India-based CDMO

Japan is the third largest pharmaceutical market in the world. (Image: iStock/Frank Lombardi Jr)

'Now is the time to include Japan' says Parexel

More Globalisation